Zhejiang Garden BiopharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 4/6
Zhejiang Garden BiopharmaceuticalLtd has a total shareholder equity of CN¥3.0B and total debt of CN¥1.6B, which brings its debt-to-equity ratio to 52.4%. Its total assets and total liabilities are CN¥5.5B and CN¥2.5B respectively. Zhejiang Garden BiopharmaceuticalLtd's EBIT is CN¥181.7M making its interest coverage ratio 8.4. It has cash and short-term investments of CN¥1.7B.
Key information
52.4%
Debt to equity ratio
CN¥1.57b
Debt
Interest coverage ratio | 8.4x |
Cash | CN¥1.72b |
Equity | CN¥3.01b |
Total liabilities | CN¥2.52b |
Total assets | CN¥5.52b |
Recent financial health updates
Recent updates
Is Zhejiang Garden BiopharmaceuticalLtd (SZSE:300401) A Risky Investment?
May 31Subdued Growth No Barrier To Zhejiang Garden Biopharmaceutical Co.,Ltd. (SZSE:300401) With Shares Advancing 27%
May 06Why Zhejiang Garden BiopharmaceuticalLtd's (SZSE:300401) Shaky Earnings Are Just The Beginning Of Its Problems
Apr 22Financial Position Analysis
Short Term Liabilities: 300401's short term assets (CN¥2.7B) exceed its short term liabilities (CN¥1.4B).
Long Term Liabilities: 300401's short term assets (CN¥2.7B) exceed its long term liabilities (CN¥1.1B).
Debt to Equity History and Analysis
Debt Level: 300401 has more cash than its total debt.
Reducing Debt: 300401's debt to equity ratio has increased from 0% to 52.4% over the past 5 years.
Debt Coverage: 300401's debt is not well covered by operating cash flow (8.3%).
Interest Coverage: 300401's interest payments on its debt are well covered by EBIT (8.4x coverage).